Stem Cell Clinic

American Academy of Stem Cell Physicians is Hosting an FDA Safety Panel, Session is Now Free to the Public – PRNewswire

By adminJuly 29, 2020Stem Cell Medicine

MIAMI, July 29, 2020 /PRNewswire/ --An FDA Safety Panel discussion will be held virtually by the American Academy of Stem Cell Physicians (AASCP) Aug.1-3, 2020, with guest speakerFDA Director Dr. Peter Marks. This is a highly anticipated session which will discuss the growing safety concerns of the industry.

The AASCP has recently created guidelines thatare current safety recommendations given to physicians who are using biologics in their medical practice. A highly anticipated and sought-after Safety StandardsPanel session will be hosted VIRTUALLY by AASCP on Aug. 1-3. 2020; guest of honor isDr. Peter Marks, FDA Director of CBER. The sessions normally are closed to the public but this particular SafetyStandard Panel discussion will be open and free to the public, covering the growing safety concerns of the industry.

The Safetypanel discussion will discuss advancements in development, manufacturing and delivery of safe and effective regenerative cell therapies through policy development, consensus and advocacy. The Safety Panel discussion willbringtogether experts and stakeholders to gain consensus on and advocate for policies that will advance the science and the field, including those focused on promoting clinical research, assuring the adoption of consensus standards to promote safety and quality, building capacity and expertise within the workforce, and establishing a national outcomes database to advance the science, promote improvements in quality and safety, and inform regulatory and patient decision-making.

According to AASCP, if physicians are using biologics in their practice, whether they are using SVF, PRP, bone marrow, UCB, amniotic products, exosomes, xenograftsor peptides, there are key considerations to take into account to achieve the best safety for their patients. The AASCP also recommends communication with the Chief Scientific Officer from the laboratory they work with. AASCP advises that just talking to a sales agent is not sufficient enough when determining the quality of products for their patients. Sales agents typically do not have a medical or scientific background.

The President for the AASCP, Dr. Martin Dayton,said earlier: "The American Academy of Stem Cell Physicians is a group of physicians, scientists and researchers who collectively represent the most authoritativenon-federal group advocating for guidelines and education on stem cell therapy and regenerative medicine. AASCP members are experts within all fields of stem cell therapy fromSVF, BM, UCB, Exosomes, Peptides, Xenografts, Allografts and Amniotic Fluids and are considered the most experienced leaders for proper advocacy in the field. The AASCP is involved directly with other authorities within the field and seeks only to bring knowledge and awareness for the ever-growing regenerative medicine industry.My hope is that the SafetyPanel discussion on Aug. 1-3, 2020, is to help get rid of the bad actors that are damaging the field for everyone."

The importance of this virtual conference coincides with the ever-emerging growthof the globalregenerative medicine marketwhich is expected to reachUSD 79.8 billionby 2024, at aCAGR of 20.5%from 2018 to 2024. Factors driving the growth of the market areincreasing prevalence of degenerative and chronic diseases, technological advancements in nanotechnology, bioengineering and stem cell therapy, and increasing geriatric population across the globe.TheAASCP virtual meeting is set for Aug. 1, 2020.List of speakers is available at http://www.aascp.net.

Due to COVID-19, the meeting will take place virtually.Thisis an effective way to ensure that everyone that wishes to participate, but cannot travel, can. Students, educators and physicians will not have to miss out on all the important topics that AASCP has on the pipeline.

Virtual Workshop Lecturers will virtually demonstrate their techniques live via their professional locations. These virtualinteractive workshops will feature small participant-to-instructor ratios with a customized curriculum focusing on developing hands-on skills. Each technique will be taught by experts in the field, using didactic sessions with dynamic multimedia presentations, live demonstrations and scanning on live models, as well as phantoms.

AASCP spokesmanDr. A.J.Farshchianexplains, "We will duplicate everything we did in our past meetings such as offer CME credits, have lectures, workshops, discuss FDA safety standards, have board examinations and a virtual graduation ceremony. AASCP is offering this virtual meeting so that nobody misses out on the education."

To join the free session via Zoom, please click on the link below at 11a.m. this Saturday.

Join Zoom Meeting: https://aascp.zoom.us/j/4150937630

Meeting ID: 415 093 7630

The American Academy of Stem Cell Physicians (AASCP) is a non-profit organization created to advance research and the development of therapeutics in regenerative medicine, including diagnosis, treatment, and prevention of disease related to or occurring within the human body. Secondarily, the AASCPaims to serve as an educational resource for physicians, scientists, and the public in diseases that can be caused by physiological dysfunction that isameliorable to medical treatment.

For further information, please contact MarieBarbaat AASCP at 305-891-4686or visit us at http://www.aascp.net.

Related Images

virtual-conference-aug-1-3-2020.jpeg Virtual Conference Aug. 1-3, 2020

aascp.png AASCP

Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 – Market Research Posts

By adminJuly 29, 2020Embryonic Stem Cells

This latest report studies Stem Cell Therapy Market globally, particularly in North America, Europe(Germany, UK, France, Italy, Spain, Russia, Poland), China, Japan, Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam) the Middle East and Africa(Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria), India, South America(Brazil, Mexico, Colombia), with revenue, import, and export, production, consumption in these regions, from 2015 to 2019, and forecast 2020 to 2027. Global Stem Cell Therapy market 2020 research report is replete with precise analysis from radical studies, specifically on queries that approach market size, trends, share, forecast, outlook, production, and futuristic developments trends and present and future market status.

Then, the report focuses on world major leading industry players with information like company profiles, product picture and specifications, Sales Revenue, Price, gross margin, market share, and contact info. In addition, the Stem Cell Therapy industry development trends and marketing channels are analyzed.

Request For Free Sample Report:

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#request_sample

Analysis of Stem Cell Therapy market Key manufacturers (Sales Revenue, Price, gross margin, main products, etc.):

Celgene Corporation Osiris Therapeutics, Inc. Pharmicell Co., Ltd MEDIPOST Co., Ltd. Promethera Biosciences Fibrocell Science, Inc. Holostem Terapie Avanzate S.r.l. Cytori Therapeutics Nuvasive, Inc. RTI Surgical, Inc. Anterogen Co., Ltd. RTI Surgical, Inc

Analysis of Stem Cell Therapy Market By Product Types(Market Size & Forecast):

Adult Stem Cells Human Embryonic Induced Pluripotent Stem Cells Very Small Embryonic Like Stem Cells

Analysis of Stem Cell Therapy Market By Applications(Market Size & Forecast):

Regenerative Medicine Drug Discovery and Development

In additional, the manufacturers dominant within the global Stem Cell Therapy Market are highlighted inside the competitive landscape section of the report. The competitive state of affairs and trends current within the market have additionally been encapsulated underneath this section of the study. moreover, the mergers and acquisitions that passed off within the market in the past few years and their impact on the markets development has in addition been bestowed underneath this a part of the report.

Ask For Discount: https://www.reportspedia.com/discount_inquiry/discount/57925

Furthermore, it describes the in-depth analysis of key Stem Cell Therapy market segments and sub-segments, particularly includes evolving Stem Cell Therapy industry trends and dynamics, challenges, and competitive insights, technological breakthroughs for Stem Cell Therapy market development mapping with different opportunities. The report also analyzes the Stem Cell Therapy industry potential for every geographical region consequently.

With the list of tables and figures, the report provides key statistics on the condition of the business and could be a valuable supply of steerage and direction for firms and people curious about the market.

Any Query Or Specific Requirement? Ask to our Research expert @

TOC of Stem Cell Therapy Market Contains Following Points:

Table of Content & Table Of Figures

See the rest here:
Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 - Market Research Posts

The surprising recovery with stem cells of 26 COVID-19 patient in Hidalgo – Explica

By adminJuly 29, 2020Stem Cell Medical Center

The treatment was applied to patients suffering from Acute Respiratory Distress Syndrome due to COVID-19. (Photo: . / Edgard Garrido)

The Governor of the State of Hidalgo, Omar Fayad Meneses, announced that through the use of mesenchymal stem cells and exosomes, 26 Hidalguenses who were severe with COVID-19 managed to recover.

This as part of a study carried out by the state government in collaboration with that of Japan, according to the newspaper El Universal. Thirty patients participated in the project, who received an innovative biotechnological therapy to treat COVID-19. They were all in serious condition, but 26 of them managed to recover as a result of the treatment.

The agreement to carry out these activities was agreed on June 13 at a meeting between the Hidalgo administration and the International Association of Cell Therapy for the New Coronavrius (IACT4C).

In presenting the results, the Governor thanked the doctor Tetsuya Fujimori and the researchers, Alex Iryiz and Sergio Alva for having been part of the project.

He assured that based on these promising results, we will seek approval in Hidalgo for this revolutionary treatment for COVID-19. In the same direction, it was reported that an authorization would be requested to make a stem cell processing center that will have a high-level technology called Prometheus.

Mexico has positioned itself in fifth place in Latin America and 13th worldwide. (Photo: . / Edgard Garrido)

Currently, the study is in its second phase, in which it is controlled and analyzes the safety and efficacy of the use of exosomes and human mesenchymal cells intravenously applied.

The Mexican media reported that the treatment was applied to patients who suffered Acute Respiratory Distress Syndrome because of COVID-19.

The president reiterated his willingness to continue collaborating with the Japanese government and that a positive aspect of the crisis is that closer ties between countries so far away are achieved.

The governor also used his Twitter account to report that to date there are 6,467 confirmed cases of COVID-19, in addition to 1,003 deaths. There are also 1,282 recovered cases and 1,282 recovered patients.

These are part of the 44,876 deaths and 402,876 confirmed cases accumulated nationwide until the 58th day of the so-called new normality. Likewise, 449,854 negative cases, 87,538 suspects and 261,457 recovered patients have been counted.

To address the pandemic, the government received on July 28, 20 ventilators for intensive care. The Ministry of Foreign Affairs (SRE) explained that the arrival of the fans was the result of cooperation between the governments of Mexico and the United States and of the conversation between the presidents. Andrs Manuel Lpez Obrador and Donald Trump on April 17, where the acquisition of equipment from that country was agreed.

The Governor thanked Dr. Tetsuya Fujimori and the researchers, Alex Iryiz and Sergio Alva for having been part of the project. (Photo: . / Edgard Garrido)

During the morning conference, the Undersecretary for Prevention and Health Promotion, Hugo Lpez-Gatell, He pointed out that in 20 states the infections of coronavirus increase day by day, however in 12 they go down.

In the mortality ranking, Mexico has positioned itself in fifth place in Latin America and 13th worldwide. About73% of deaths were associated with at least one comorbidity, mainly hypertension, diabetes and obesity.

Actually, Mexico City continues to be the entity with the highest number of active casesfollowed by Guanajuato, Nuevo Len, which rose by one place, Estado de Mxico, Veracruz, which rose by two places, Tabasco, Coahuila, which rose by one site, Jalisco, Yucatan, rose by one place, and Puebla.

R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico – PR Web

By adminJuly 29, 2020Stem Cell Treatment

Four Stem Cell Joint Injections for Only $3950! (888) 988-0515

SCOTTSDALE, Ariz. (PRWEB) July 29, 2020

R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950. With 50 million stem cells total, patients may choose which extremities they would like treated.

Several studies have shown just how well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with a long history of accreditation and pristine safety record. The lab abides by quality assurance standards that exceed those of the FDA.

Stem cell treatment for knees in Mexico at R3 works amazingly well. Patient satisfaction surveys at the center reveal that nine out of ten patients say they would have the procedure again and recommend it to friends and family.

According to R3 CEO David Greene, MD, MBA, "The biologics don't need preservative and viability exceeds 95%. The pureness and potency truly makes the difference in outcomes. Four joints for under $4000? What we put together for patients is incredible!"

The treatment process begins with a free phone consultation with one of R3's licensed, experienced stem cell doctors. Because the treatment includes 50 million stem cells, four joints may be included. The dedicated patient concierge representative assists with travel logistics. Travel from San Diego is included to the clinic, which is only 20 minutes from the San Diego airport.

Image guidance is used at the Center to ensure injection accuracy. In addition to arthritis treatment, R3 International offers stem cell treatment for autism, Lyme, COPD, kidney failure, neuropathy, diabetes, MS, ALS, stroke and much more.

Call (888) 988-0515 to learn more about therapies offered, and visit https://stemcelltreatmentclinic.com to read about the process.

Share article on social media or email:

The rest is here:
R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico - PR Web

Impact of COVID-19 on Cell Freezing Media for Cell Therapy Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 -…

By adminJuly 29, 2020Stem Cell Treatment

Innovative Report on Cell Freezing Media for Cell Therapy Market with Competitive Analysis, New Business Developments, and Top Companies

A perfect mix of quantitative & qualitative Cell Freezing Media for Cell Therapy Market Market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Cell Freezing Media for Cell Therapy Market. The study bridges the historical data from 2014 to 2019 and estimated until 2026.

Prominent players profiled in the study: BioLife Solutions, Akron Biotechnology, GE Healthcare, Thermo Fisher Scientific, Biological Industries, Merck, WAK-Chemie Medical, Zenoaq

Sample Report with Latest Industry Trends @https://www.acquiremarketresearch.com/sample-request/379423/

Covid-19 pandemic affects most industries in the globe. Here at acquire market research we offer you comprehensive data of related industry which will help and support your business in all possible ways.

This Report Provides an overview of the Cell Freezing Media for Cell Therapy market, containing global revenue, global production, sales, and CAGR. Also describe Cell Freezing Media for Cell Therapy product scope, market overview, market opportunities, market driving force, and market risks. The forecast and analysis of the Cell Freezing Media for Cell Therapy market by type, application, and region are also presented. The next part of the report provides a full-scale analysis of Cell Freezing Media for Cell Therapy competitive situation, sales, revenue and global market share of major players in the Cell Freezing Media for Cell Therapy industry. The basic information, as well as the profiles, applications, and specifications of products market performance along with Business Overview, are offered.

With FBS, Without FBS: With FBS, Without FBS

Application: Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Other

Geographical Regions: North America, Europe, Central & South America, Asia-Pacific, and the Middle East & Africa, etc.

Get Reasonable Discount on this Premium Report @https://www.acquiremarketresearch.com/discount-request/379423/

Scope of the Cell Freezing Media for Cell Therapy Report:

Worldwide Cell Freezing Media for Cell Therapy Market 2020, Market Size Value CAGR (XX %) and revenue (USD Million) for the historical years (2016 to 2019) and forecast years (2020 to 2026), with SWOT analysis, Industry Analysis, Demand, Sales, Market Drivers, Restraints, Opportunities and Forecast to 2026 cover in this research report.

As a part of our Corporate Social Responsibility, we would like to announce that we would be contributing 15 % of our profits to USA, UK, Italy, Spain and India relief fund.

This report covers the current scenario and growth prospects of the Cell Freezing Media for Cell Therapy Market for the period 2020-2026. The study is a professional and in-depth study with around tables and figures which provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the domain.

Finally, all aspects of the Global Cell Freezing Media for Cell Therapy Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and future prospects.

Browse Full [emailprotected] https://www.acquiremarketresearch.com/industry-reports/cell-freezing-media-for-cell-therapy-market/379423/

About us:

Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.

Sally Mach 555 Madison Avenue, 5th Floor, Manhattan, New York, 10022 USA Phone No.: +1 (800) 663-5579 Email ID: [emailprotected]

Here is the original post:
Impact of COVID-19 on Cell Freezing Media for Cell Therapy Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 -...

Tooth Regeneration Market Size -Future of growth, Top Capital Facts, Global Industry Analysis, Share, Growth, Trends and Forecast 2020 – 2025 – Market…

By adminJuly 29, 2020Somatic Stem Cells

Detailed Analysis & SWOT analysis, Tooth Regeneration Market Trends 2020, Tooth Regeneration Market Growth 2020, Tooth Regeneration Industry Share 2020, Tooth Regeneration Industry Size, Tooth Regeneration Market Research, Tooth Regeneration Market Analysis,

GlobalTooth Regeneration Marketreport tends to a portion of the major and one of a kind parts of the market. Further report makes reference to mechanical norms based on planned degree and industry measurement and uncovers. Based on notable information, showcase size has been determined as far as income from base year 2020 to 2025.

The global Tooth Regeneration market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2024.

Get a sample copy of the Tooth Regeneration market report 2020

Tooth Regeneration Industry Outlook 2020:->

Tooth regeneration is a stem cell based regenerative medicine procedure in the field of tissue engineering and stem cell biology to replace damaged or lost teeth by regrowing them from autologous stem cells. As a source of the new bioengineered teeth somatic stem cells are collected and reprogrammed to induced pluripotent stem cells which can be placed in the dental lamina directly or placed in a reabsorbable biopolymer in the shape of the new tooth.,

Tooth Regeneration market competition by top Countries manufacturers/ Key player Data Profiled:

And More

Get a Sample PDF of report @https://www.marketgrowthreports.com/enquiry/request-sample/14428634

Scope of the Tooth Regeneration MarketReport:

Tooth Regeneration Market Segment by Type covers:

Tooth Regeneration Market Segment by Applications can be divided into:

Regional analysis covers:

Fill the Pre-Order Enquiry form for the report @https://www.marketgrowthreports.com/enquiry/pre-order-enquiry/14428634

This Tooth Regeneration Market Research/Analysis Report Contains Answers to your following Questions

Key Benefits

And More.

Look into Table of Content of Tooth Regeneration Market Report @https://www.marketgrowthreports.com/TOC/14428634#TOC

The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information,growth rateof Tooth Regeneration market in 2025is also explained.Additionally, type wise and application wise consumptiontables andfiguresof Tooth Regeneration marketare also given.

Buy this report (Price USD 3480 for a single-user license)@https://www.marketgrowthreports.com/purchase/14428634

About 360 Market Updates:

360 Market Updates is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

Mr. Ajay More

Phone:+14242530807 / + 44 20 3239 8187

Email:[emailprotected]

For More Related Reports Click Here :

Virtual Cards Market Size 2020 : Growth Factors, Business Opportunity,Segmentation and Forecast to 2026 Research Reportby implies ofMarket Growth Reports

LED Materials Market Size 2020 : Growth Factors, Business Opportunity,Segmentation and Forecast to 2026 Research Reportby implies ofMarket Growth Reports

Vulkollan Wheels Market Size and Growth, Sales Revenue, Key Players Analysis, Development Status, Opportunity Assessment and Industry Expansion Strategies 2025 Research ReportthroughMarket Growth Reports

Seamless Steel Tube Market Size, Growth Opportunities, Emerging Technologies, Trends,Growth, Segments, Landscape and Demandby route ofForecast to 2026 Research Reportwith the guide ofMarket Growth Reports

Chocolate Ice Cream Market Size, Growth Opportunities, Emerging Technologies, Trends,Growth, Segments, Landscape and Demandby usingForecast to 2026 Research ReportviaMarket Growth Reports

Read the rest here:
Tooth Regeneration Market Size -Future of growth, Top Capital Facts, Global Industry Analysis, Share, Growth, Trends and Forecast 2020 - 2025 - Market...

Somatic Stem Cells | SpringerLink

By adminJuly 29, 2020Somatic Stem Cells

Stem cells are found in almost all organisms from the early stages of development to the end of life. There are several types of stem cells and all of them may prove useful for medical research; however, each of the different types has both promise and limitations. Somatic Stem Cells: Methods and Protocols presents selected genetic, molecular, and cellular techniques used in somatic stem cell research and its clinical application. Chapters focus on the isolation, characterization, purity, plasticity, and clinical uses of somatic stem cells from a variety of human and animal tissues. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls.

Through and intuitive, Somatic Stem Cells: Methods and Protocols seeks to provides scientists with the fundamental techniques of stem cell research and its potential application in regenerative medicine.

Somatic Stem cells anticancer therapies embryonic stem cells pluripotent stem cells regenerative medicine stem cell differentiation stem cell proliferation tissue homeostasis

Link:
Somatic Stem Cells | SpringerLink

Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health – Yahoo Finance

By adminJuly 29, 2020Stell Cell Research

Boehringer Ingelheim, a market leader in animal health, has acquired Global Stem cell Technology (GST), a Belgian veterinary biotech company. GST is dedicated to the research, development and production of evidence-based, regenerative medicines (stem cell therapies) used to treat orthopedic and metabolic diseases in animals. Boehringer Ingelheim already entered into a partnership with GST in 2018; in 2019, the companies launched Arti-Cell Forte in Europe.

Arti-Cell Forte is testimony to the innovation strength that lies within both companies. It is the first-ever stem cell product in the veterinary world granted marketing authorization by the European Commission. The acquisition and integration of GST will accelerate the development pipeline of Boehringer Ingelheim while maintaining its focus on setting new standards of care for animals.

"Collaboration with external partners plays an essential role in helping us expand our portfolio. After two years of a very successful partnership, we have decided to acquire GST. We are convinced that its expertise in the field of state-of-the art stem cell products will help us bring even more innovative solutions to our customers," shares Jean-Luc Michel, Head of Global Strategic Marketing, Boehringer Ingelheim Animal Health.

"Boehringer Ingelheim wants to lead a new wave of innovation in the veterinary field. This ambition is a natural fit with GSTs management, staff and vision. From the very beginning we aimed to change the veterinary field, a role we will continue to play as a new R&D division within Boehringer Ingelheim," says Jan Spaas, CEO of GST.

"This decision is fully aligned with our recently refocused strategic direction. Stem cell research areas and regenerative medicine offer an exciting potential for the next wave of innovation we are actively pursuing. In addition, strengthening external partnerships to accelerate our innovative efforts and growth is one of the key elements of our strategy," adds Eric Haaksma, Head of Global Innovation at Boehringer Ingelheim Animal Health.

The companies did not disclose the financial terms of the deal.

For references and notes to editors, please visit:

http://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-acquires-global-stem-cell-technology

Intended audiences:

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200727005234/en/

Contacts

Boehringer Ingelheim Animal Health Communication Tereza Urbankova 552 16 Ingelheim, Germany Phone: +49 6132 77 184817 Email: press@boehringer-ingelheim.com

The rest is here:
Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health - Yahoo Finance

Human Embryonic Stem Cells (HESC) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026|ESI BIO, Thermo Fisher, BioTime -…

By adminJuly 29, 2020Stell Cell Research

QY Research has Published Latest Trending Report on Global Human Embryonic Stem Cells (HESC) Market

Los Angeles, United State, The report titledGlobal Human Embryonic Stem Cells (HESC) Marketis one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Human Embryonic Stem Cells (HESC) market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Human Embryonic Stem Cells (HESC) market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Human Embryonic Stem Cells (HESC) market is carefully analyzed and researched about by the market analysts.

Request Sample Report and Full Report TOC:https://www.qyresearch.com/sample-form/form/1749373/covid-19-impact-on-human-embryonic-stem-cells-hesc-market

The Essential Content Covered in the GlobalHuman Embryonic Stem Cells (HESC) Market Report:

* Top Key Company Profiles. * Main Business and Rival Information * SWOT Analysis and PESTEL Analysis * Production, Sales, Revenue, Price and Gross Margin * Market Share and Size

Global Human Embryonic Stem Cells (HESC) Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026. According to the latest report added to the online repository of QY Research the Human Embryonic Stem Cells (HESC) market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Top Players of Human Embryonic Stem Cells (HESC) Market are Studied: ESI BIO, Thermo Fisher, BioTime, MilliporeSigma, BD Biosciences, Astellas Institute of Regenerative Medicine, Asterias Biotherapeutics, Cell Cure Neurosciences, PerkinElmer, Takara Bio, Cellular Dynamics International, Reliance Life Sciences, Research & Diagnostics Systems, SABiosciences, STEMCELL Technologies, Stemina Biomarker Discovery, Takara Bio, TATAA Biocenter, UK Stem Cell Bank, ViaCyte, Vitrolife, etc.

The report provides a 6-year forecast (2020-2026) assessed based on how the Human Embryonic Stem Cells (HESC) market is predicted to grow in major regions likeUSA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.

Segmentation by Type:, Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells

Segmentation by Application:, Research, Clinical Trials, Others

Reasons to Buy this Report:

Table of Contents

1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Car Sealed lead-acid Battery Industry 1.7 COVID-19 Impact: Car Sealed lead-acid Battery Market Trends 2 Global Car Sealed lead-acid Battery Quarterly Market Size Analysis 2.1 Car Sealed lead-acid Battery Business Impact Assessment COVID-19 2.1.1 Global Car Sealed lead-acid Battery Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.1.2 Global Car Sealed lead-acid Battery Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Car Sealed lead-acid Battery Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 Global Car Sealed lead-acid Battery Quarterly Market Size by Manufacturers, 2019 VS 2020 3.2 Global Car Sealed lead-acid Battery Factory Price by Manufacturers 3.3 Location of Key Manufacturers Car Sealed lead-acid Battery Manufacturing Factories and Area Served 3.4 Date of Key Manufacturers Enter into Car Sealed lead-acid Battery Market 3.5 Key Manufacturers Car Sealed lead-acid Battery Product Offered 3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Car Sealed lead-acid Battery Segments, By Type 4.1 Introduction 1.4.1 AGM Battery 1.4.2 Gel Battery 4.2 By Type, Global Car Sealed lead-acid Battery Market Size, 2019-2021 4.2.1 By Type, Global Car Sealed lead-acid Battery Market Size by Type, 2020-2021 4.2.2 By Type, Global Car Sealed lead-acid Battery Price, 2020-2021 5 Impact of Covid-19 on Car Sealed lead-acid Battery Segments, By Application 5.1 Overview 5.5.1 Passenger Vehicle 5.5.2 Commercial Vehicle 5.2 By Application, Global Car Sealed lead-acid Battery Market Size, 2019-2021 5.2.1 By Application, Global Car Sealed lead-acid Battery Market Size by Application, 2019-2021 5.2.2 By Application, Global Car Sealed lead-acid Battery Price, 2020-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Johnson Controls 7.1.1 Johnson Controls Business Overview 7.1.2 Johnson Controls Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.1.3 Johnson Controls Car Sealed lead-acid Battery Product Introduction 7.1.4 Johnson Controls Response to COVID-19 and Related Developments 7.2 GS Yuasa 7.2.1 GS Yuasa Business Overview 7.2.2 GS Yuasa Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.2.3 GS Yuasa Car Sealed lead-acid Battery Product Introduction 7.2.4 GS Yuasa Response to COVID-19 and Related Developments 7.3 Exide Technologies 7.3.1 Exide Technologies Business Overview 7.3.2 Exide Technologies Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.3.3 Exide Technologies Car Sealed lead-acid Battery Product Introduction 7.3.4 Exide Technologies Response to COVID-19 and Related Developments 7.4 Hitachi Chemical 7.4.1 Hitachi Chemical Business Overview 7.4.2 Hitachi Chemical Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.4.3 Hitachi Chemical Car Sealed lead-acid Battery Product Introduction 7.4.4 Hitachi Chemical Response to COVID-19 and Related Developments 7.5 Camel Group 7.5.1 Camel Group Business Overview 7.5.2 Camel Group Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.5.3 Camel Group Car Sealed lead-acid Battery Product Introduction 7.5.4 Camel Group Response to COVID-19 and Related Developments 7.6 Sebang 7.6.1 Sebang Business Overview 7.6.2 Sebang Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.6.3 Sebang Car Sealed lead-acid Battery Product Introduction 7.6.4 Sebang Response to COVID-19 and Related Developments 7.7 Atlas BX 7.7.1 Atlas BX Business Overview 7.7.2 Atlas BX Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.7.3 Atlas BX Car Sealed lead-acid Battery Product Introduction 7.7.4 Atlas BX Response to COVID-19 and Related Developments 7.8 CSIC Power 7.8.1 CSIC Power Business Overview 7.8.2 CSIC Power Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.8.3 CSIC Power Car Sealed lead-acid Battery Product Introduction 7.8.4 CSIC Power Response to COVID-19 and Related Developments 7.9 East Penn 7.9.1 East Penn Business Overview 7.9.2 East Penn Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.9.3 East Penn Car Sealed lead-acid Battery Product Introduction 7.9.4 East Penn Response to COVID-19 and Related Developments 7.10 Banner Batteries 7.10.1 Banner Batteries Business Overview 7.10.2 Banner Batteries Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.10.3 Banner Batteries Car Sealed lead-acid Battery Product Introduction 7.10.4 Banner Batteries Response to COVID-19 and Related Developments 7.11 Chuanxi Storage 7.11.1 Chuanxi Storage Business Overview 7.11.2 Chuanxi Storage Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.11.3 Chuanxi Storage Car Sealed lead-acid Battery Product Introduction 7.11.4 Chuanxi Storage Response to COVID-19 and Related Developments 7.12 Exide Industries 7.12.1 Exide Industries Business Overview 7.12.2 Exide Industries Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.12.3 Exide Industries Car Sealed lead-acid Battery Product Introduction 7.12.4 Exide Industries Response to COVID-19 and Related Developments 7.13 Ruiyu Battery 7.13.1 Ruiyu Battery Business Overview 7.13.2 Ruiyu Battery Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.13.3 Ruiyu Battery Car Sealed lead-acid Battery Product Introduction 7.13.4 Ruiyu Battery Response to COVID-19 and Related Developments 7.14 Amara Raja 7.14.1 Amara Raja Business Overview 7.14.2 Amara Raja Car Sealed lead-acid Battery Quarterly Production and Revenue, 2020 7.14.3 Amara Raja Car Sealed lead-acid Battery Product Introduction 7.14.4 Amara Raja Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis 8.1 Car Sealed lead-acid Battery Supply Chain Analysis 8.1.1 Car Sealed lead-acid Battery Supply Chain Analysis 8.1.2 Covid-19 Impact on Car Sealed lead-acid Battery Supply Chain 8.2 Distribution Channels Analysis 8.2.1 Car Sealed lead-acid Battery Distribution Channels 8.2.2 Covid-19 Impact on Car Sealed lead-acid Battery Distribution Channels 8.2.3 Car Sealed lead-acid Battery Distributors 8.3 Car Sealed lead-acid Battery Customers 9 Key Findings 10 Appendix 10.1 About Us 10.2 Disclaimer

About US

QY Research is a leading global market research and consulting company. Established in 2007 in Beijing, China, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services.

Link:
Human Embryonic Stem Cells (HESC) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026|ESI BIO, Thermo Fisher, BioTime -...

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy – Business Wire

By adminJuly 29, 2020Stem Cell Treatment

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce an expansion of its collaboration and license agreement with Daewoong Pharmaceutical Co. Ltd. (KSX: 069620) and AffyXell Therapeutics, the joint venture established in South Korea by the two companies, to develop stem cell treatments incorporating Avactas neutralising Affimer therapy for the treatment of seriously ill patients with COVID-19 and to also prepare to rapidly develop similar therapies for future global pandemics.

Respiratory diseases such as COVID-19 can cause serious damage to the lungs as a consequence of over-activation of the patient's immune system, resulting in cytokine release syndrome that can potentially lead to multiple organ failure and death. Stem cell therapies offer a very promising approach to repair the damage to lung tissues in these pulmonary diseases by controlling the immune balance.

AffyXell Therapeutics, the next-generation cell and gene therapy joint venture between Avacta and Daewoong Pharmaceutical, is developing a novel class of mesenchymal stem cell (MSC) treatments that are engineered to also produce Affimer therapies in the patient at the site of action.

The expansion of the agreement between Avacta, Daewoong Pharmaceutical and AffyXell announced today extends the scope of the partnership to include Affimer molecules that target viruses, such as coronaviruses, in order to develop therapies that repair the lung damage caused by COVID-19 whilst also producing neutralising Affimer molecules to prevent the progression of the disease.

AffyXell will engineer mesenchymal stem cells to express SARS-COV-2 neutralising Affimer molecules in order to develop treatments for seriously ill COVID-19 patients, and will also prepare for rapid development of next-generation stem cell therapies for future infectious respiratory disease outbreaks.

Dr. Alastair Smith, Chief Executive of Avacta Group commented: I am very pleased to have extended our collaboration and license agreement with Daewoong Pharmaceutical to include the SARS-COV-2 neutralising Affimer molecules for the treatment of COVID-19 and to create the potential to respond very rapidly in future to global virus threats.

AffyXell will address the need over the coming years for advanced stem cell therapies to treat lung damage caused by cytokine release syndrome suffered by COVID-19 patients and, at the same time, help prevent disease progression in these patients through the action of a neutralising Affimer therapy.

More broadly, one of the key areas of unmet clinical need that AffyXell can address with its next-generation mesenchymal stem cell therapies is acute pulmonary diseases such as COPD and acute respiratory distress syndrome. We, and our partners in South Korea, are very excited by the potential to develop life improving treatments for patients with these serious respiratory diseases as well as COVID-19.

I look forward to further updating the market on progress in our ground-breaking programmes with AffyXell in due course, and on progress with our COVID-19 diagnostics programmes shortly.

Seng-ho Jeon, CEO of Daewoong Pharmaceutical and AffyXell Therapeutics, commented:

It is very encouraging that AffyXell now has the opportunity to expand the application of its next-generation stem cell platform technology to target viruses. The SARS-COV-2 neutralising Affimer to be developed in combination with AffyXells cell and gene technology is expected to be an innovative solution for COVID-19 patients suffering cytokine release syndrome.

Daewoong has been also conducting several research programs and clinical trial for COVID-19. As the COVID-19 crisis has caused great difficulties worldwide, we will continue to focus our efforts to develop a novel therapeutic agent for COVID-19.

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).

See the original post:
Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy - Business Wire